Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antares Pharma to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.


EWING, N.J. -- Antares Pharma (AMEX AMEX

See: American Stock Exchange
:AIS), announced that Jack E. Stover, President & Chief Executive Officer, is scheduled to present at the BioFin Rodman & Renshaw Healthcare Conference on Wednesday, November 7 at 9:30 am Eastern at the Palace Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 . A live webcast of the audio portion of this presentation will be available via http://www.wsw.com/webcast/rrshq12/ais and can be replayed until February 7, 2007.

About Antares Pharma

Antares Pharma is a specialized pharma product development company committed to improving pharmaceuticals through its patented drug delivery systems. Antares has three validated drug delivery platforms: the ATD ATD Anthropomorphic Test Dummy
ATD Attention to Detail
ATD Advanced Technology Demonstration
AtD Achieving the Dream
ATD Atmospheric Technology Division (US National Center for Atmospheric Research)
ATD Assistant Technical Director
(TM) Advanced Transdermal Delivery system transdermal delivery system: see skin patch. , subcutaneous injection technology platforms including both Vibex(TM) disposable mini-needle injection device and Valeo(TM)/Vision[R] reusable needle-free injection devices; and Easy Tec(TM) oral fast-melt technology. Two of the platforms have generated FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved products. Antares Pharma leverages its multiple drug delivery platforms to add value to existing drugs and to create new pharmaceutical products and injectable devices. The Company's products are engineered to improve safety and efficacy profiles by minimizing dosing and reducing side effects Side effects

Effects of a proposed project on other parts of the firm.
 while enabling improved patient compliance. Antares Pharma has corporate headquarters in Ewing, New Jersey, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapolis, Minnesota and Basel, Switzerland.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:Oct 29, 2007
Words:217
Previous Article:Watsco to Present At JPMorgan SMid Cap Conference.
Next Article:Dade Behring Reports Strong Earnings and Revenue Growth for the Third Quarter and First Nine Months of 2007.
Topics:



Related Articles
Antares Pharma to Present at Rodman & Renshaw 8th Annual Healthcare Conference.
NitroMed to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.
VIVUS To Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference.
Dyax Corp. To Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference.
Avalon Pharmaceuticals to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference.
Become a NAMA advocate.
Rexahn Pharmaceuticals, Inc. to Present at the Acumen BioFin 9th Annual Healthcare Conference.
Depomed to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.
Genitope Corporation to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.
AVEO Pharmaceuticals to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles